Atomoxetine

Description

Atomoxetine is used for the treatment of attention-deficit hyperactivity disorder (ADHD), a chronic condition characterized by symptoms such as difficulty in paying attention, impulsiveness, hyperactivity, etc. This medicine is not recommended for use in patients less than 6 years of age.

Side effects

Major & minor side effects for Atomoxetine

  • Itching
  • Skin Rash
  • Dizziness
  • Cough
  • Headache
  • Fever
  • Nausea and Vomiting
  • Shortness of breath
  • Abnormal dreams
  • Back pain

Uses of Atomoxetine

What is it prescribed for?

  • ADHD
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of this medicine is cumulative and it may take up to 4 weeks of therapy before a marked effect is observed.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to atomoxetine or any other inactive ingredients present along with it.

Narrow angle glaucoma

This medicine is not recommended for use in patients suffering from narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors (MAOI)

This medicine is not recommended for use in patients receiving therapy with monoamine oxidase inhibitors or within 2 weeks of discontinuing therapy with a monoamine oxidase inhibitor due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings

Driving or Operating Machinery

This medicine may cause symptoms such as blurred vision, dizziness, drowsiness, tiredness, weakness, etc. in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Urinary Retention

This medicine should be used with extreme caution in patients suffering from urinary disorders due to the increased risk of severe adverse effects such as urinary retention and urinary hesitancy. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Liver Diseases

This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Suicidal Tendency

This medicine may increase the risk of suicidal thoughts in some patients. This risk is especially higher in patients suffering from depression and other psychiatric disorders. Patients should be monitored closely for any change in mood or behavior during treatment with this medicine. Appropriate caregiver/patient counseling, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Use in children

This medicine is not recommended for use in patients less than 6 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Imatinib Mesylate

Ivabradine

Ofloxacin

Azithromycin

Citalopram

Haloperidol

Clozapine

Dopamine

Disease interactions

Liver Disease

This medicine should be used with extreme caution in patients with a history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Renal Dysfunction

This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Seizure disorders

This medicine should be used with extreme caution in patients suffering from seizures disorder due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Psychiatric disorders

This medicine should be used with extreme caution in patients suffering from psychiatric disorders due to the increased risk of worsening of the patient's condition. Patients should be monitored closely for any change in mood and behavior during treatment with this medicine. Appropriate caregiver/patient counseling, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Cardiovascular disease

This medicine should be used with extreme caution in patients suffering from cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by increasing the levels of certain chemical substances in the brain that help in controlling hyperactivity and impulsiveness.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

CNS stimulants

Schedule

Schedule H

Atomoxetine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 27 July 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a603013.html

Atomoxetine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 27 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB00289

[Internet]. Medsafe.govt.nz. 2018 [cited 27 July 2018]. Available from:

http://www.medsafe.govt.nz/profs/Datasheet/s/Stratteracap.pdf

[Internet]. Accessdata.fda.gov. 2018 [cited 27 July 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021411s035lbl.pdf

[Internet]. Medicines.org.uk. 2018 [cited 27 July 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.7433.pdf

[Internet]. Pi.lilly.com. 2018 [cited 27 July 2018]. Available from:

http://pi.lilly.com/ca/strattera-ca-pmi.pdf

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Aug 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.